Galvin Gaustad & Stein’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$719K Hold
2,042
0.06% 147
2025
Q4
$668K Hold
2,042
0.05% 148
2025
Q3
$576K Buy
2,042
+1
+0% +$290 0.05% 135
2025
Q2
$570K Sell
2,041
-50
-2% -$14.2K 0.05% 131
2025
Q1
$651K Sell
2,091
-197
-9% -$58.2K 0.06% 116
2024
Q4
$596K Buy
2,288
+380
+20% +$113K 0.05% 121
2024
Q3
$615K Sell
1,908
-124
-6% -$40.6K 0.05% 119
2024
Q2
$635K Sell
2,032
-115
-5% -$33.8K 0.06% 110
2024
Q1
$610K Sell
2,147
-575
-21% -$168K 0.06% 111
2023
Q4
$784K Sell
2,722
-1,016
-27% -$277K 0.07% 101
2023
Q3
$1M Sell
3,738
-17,285
-82% -$4.31M 0.1% 86
2023
Q2
$4.67M Buy
21,023
+4,730
+29% +$1.1M 0.45% 61
2023
Q1
$3.94M Buy
16,293
+14,440
+779% +$3.54M 0.39% 62
2022
Q4
$487K Sell
1,853
-20,910
-92% -$5.61M 0.05% 116
2022
Q3
$5.13M Sell
22,763
-2,760
-11% -$669K 0.54% 58
2022
Q2
$6.21M Sell
25,523
-7,777
-23% -$1.91M 0.63% 56
2022
Q1
$8.05M Buy
33,300
+2,900
+10% +$666K 0.73% 53
2021
Q4
$6.84M Buy
30,400
+3,136
+12% +$662K 0.59% 60
2021
Q3
$5.8M Buy
27,264
+24,125
+769% +$5.55M 0.56% 61
2021
Q2
$765K Sell
3,139
-27
-0.9% -$6.64K 0.07% 115
2021
Q1
$788K Buy
3,166
+21
+0.7% +$5.01K 0.08% 114
2020
Q4
$723K Buy
+3,145
New +$725K 0.08% 116

Other funds holding AMGN

Galvin Gaustad & Stein's AMGN Position: Q1 2026 in Review

Galvin Gaustad & Stein held its Amgen (AMGN) position steady in Q1 2026 at 2,042 shares worth $719K. The position accounts for 0.06% of the portfolio, ranked #147.

Galvin Gaustad & Stein first reported a position in AMGN in Q4 2020 and has held it in 22 quarters since. The position peaked at $8.05M in Q1 2022. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Galvin Gaustad & Stein held 2,042 shares of Amgen worth $719K as of Q1 2026.
  • Galvin Gaustad & Stein left its Amgen share count unchanged in Q1 2026.
  • Amgen made up 0.06% of Galvin Gaustad & Stein's portfolio in Q1 2026, its #147 holding.
  • Galvin Gaustad & Stein first reported a position in Amgen in Q4 2020 and has held it in 22 quarters since.
  • Galvin Gaustad & Stein's Amgen position peaked at $8.05M in Q1 2022.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Galvin Gaustad & Stein's 13F filing for Q1 2026, filed 14 May 2026.